Both medications act on GLP-1 receptors, which are found throughout the body, including in the brain, stomach, intestines, pancreas, and even fat cells
This comprehensive research program will help determine the medications full potential across multiple conditions
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin in type 2 diabetes mellitus (LEAD-2 Met)
The protective effects of GIP on the bone have been also observed in humans with and without diabetes [43, 44]
[17] [18] Once reconstituted, the peptide is no longer protected by the stable, dehydrated matrix of the lyophilised form
Data suggests that these effects are being mediated through key pathways such as WNT/-catenin, MAPK, BMP/Smad and ERK